发明名称 CASPASE INHIBITOR
摘要 The present invention relates to an isoxazoline derivative of formula (I), t he pharmaceutically acceptable salts, esters and stereochemically isomeric form s thereof, and the use of the derivative in inhibiting the activity of caspase s. The present invention also relates to a pharmaceutical composition for preventing inflammation and apotosis which comprises the isoxazoline derivative, pharmaceutically acceptable salts, esters and stereochemically isomeric forms thereof and the process for preparing the same. The derivativ e according to the present invention can be effectively used in treating diseases due to caspases, such as, for example the disease in which cells ar e abnormally died, dementia, cerebral stroke, AIDS, diabetes, gastric ulcer, hepatic injure by hepatitis, sepsis, organ transplantation rejection reactio n and anti-inflammation.
申请公布号 CA2388564(A1) 申请公布日期 2001.03.29
申请号 CA20002388564 申请日期 2000.09.18
申请人 LG CHEM INVESTMENT LTD. 发明人 PARK, TAE-KYO;CHANG, HYE-KYUNG;CHUNG, HYUN-HO;KIM, YOUNG-MYEONG;KANG, CHANG-YUIL;KIM, EUNICE EUN-KYEONG;MIN, CHANG-HEE;LEE, TAE-HEE;PARK, MI-JEONG;MOON, KWANG-YUL;OH, YOUNG-LEEM
分类号 C07D261/04;A61K31/42;A61K31/422;A61K31/454;A61K31/4709;A61K31/4725;A61P1/04;A61P1/16;A61P3/10;A61P9/00;A61P9/10;A61P19/02;A61P25/28;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P31/20;A61P37/00;A61P37/02;A61P43/00;C07B61/00;C07D261/18;C07D413/12;C07D413/14;C07D521/00;(IPC1-7):C07D413/12;A61K31/41 主分类号 C07D261/04
代理机构 代理人
主权项
地址